immune system
• B cell differentiation from pro-B cells into pre-B and immature cells is disrupted compared to in wild-type mice
• mice exhibit less transition of pro-B cells from immunoglobulin- to immunoglobulin+ cells compared with wild-type mice
|
• in the bone marrow
|
• in the spleen
|
• mice exhibit decreased B cell frequency in the blood, peritoneal cavity, and spleen compared with wild-type mice
|
• in the bone marrow and spleen
|
• in the bone marrow
|
• in the peritoneal cavity
|
• in the peritoneal cavity
|
• in the peritoneal cavity
|
• in the peritoneal cavity
|
• in the bone marrow
|
• in the spleen
|
• mice treated with inactivated Bordetella pertussis or alum-precipitated chicken gamma-globulin (CGG) coupled to the hapten azo-benzene-arsonate (ABA) exhibit reduced antibody response compared with wild-type mice
• booster immunization with ABA-CGG failed to produce anti-ABA antibodies unlike in wild-type mice
• however, antibody response to NP-Ficoll is normal
|
neoplasm
• in all months at 6 months of age with areas of hemorrhage, necrosis, and hypervascularity
|
homeostasis/metabolism
• 30-fold
|
hematopoietic system
N |
• mice exhibit normal numbers of major blood cell progenitors and lineages in the bone marrow
|
• B cell differentiation from pro-B cells into pre-B and immature cells is disrupted compared to in wild-type mice
• mice exhibit less transition of pro-B cells from immunoglobulin- to immunoglobulin+ cells compared with wild-type mice
|
• in the bone marrow
|
• in the spleen
|
• mice exhibit decreased B cell frequency in the blood, peritoneal cavity, and spleen compared with wild-type mice
|
• in the bone marrow and spleen
|
• in the bone marrow
|
• in the peritoneal cavity
|
• in the peritoneal cavity
|
• in the peritoneal cavity
|
• in the peritoneal cavity
|
• in the bone marrow
|
• in the spleen
|
liver/biliary system
• in all months at 6 months of age with areas of hemorrhage, necrosis, and hypervascularity
|